Celleste Bio

Celleste Bio

Private
Tel AvivHealthcare & Life Scienceshttps://celleste-bio.com

Last Round

Seed

Dec 5, 2024

Total Funding Raised

$4.5M

Momentum Score

50 /100

Company Overview

Celleste Bio is a biotechnology company that produces cocoa ingredients using cell culture methods to create a sustainable supply chain.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Supply Chain, Sustainable Materials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

cellular agriculturecell-cultured cocoacocoa butterfood-techlab grown chocolatebeanless chocolateplant cell culturesustainable cocoacell agB2B ingredientsdeforestation-free cocoacocoa powderbioreactor productioncocoa supply chainconfectionery ingredientscustomized ingredients

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Celleste Bio Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Celleste Bio Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
SeedDec 5, 2024
SeedNov 7, 2022

Key People

Founding team and executive leadership

Hanne Volpin

Co-Founder, CTO

Founding Team

Michal Beressi Golomb

Chief Executive Officer

Executive Team

Celleste Bio Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 17, 2026

    Partnered with Mondelez International for cultured cocoa butter chocolate samples.

  • Oct 16, 2025

    Launched cell-cultured cocoa butter to address supply chain issues.

Celleste Bio Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Celleste Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Celleste Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersTel Aviv
Employee Range21
Year Founded2022
Last FundingDec 5, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.